- Home
- RVYL vs SBFM Comparison
RVYL vs SBFM Comparison
Compare RVYL & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVYL
- SBFM
- Stock Information
- Founded
- RVYL 2007
- SBFM 2006
- Country
- RVYL United States
- SBFM United States
- Employees
- RVYL N/A
- SBFM N/A
- Industry
- RVYL Professional Services
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- RVYL Consumer Discretionary
- SBFM Health Care
- Exchange
- RVYL Nasdaq
- SBFM Nasdaq
- Market Cap
- RVYL 7.3M
- SBFM 6.7M
- IPO Year
- RVYL N/A
- SBFM N/A
- Fundamental
- Price
- RVYL $0.31
- SBFM $1.75
- Analyst Decision
- RVYL Hold
- SBFM Strong Buy
- Analyst Count
- RVYL 1
- SBFM 1
- Target Price
- RVYL N/A
- SBFM $7.00
- AVG Volume (30 Days)
- RVYL 9.6M
- SBFM 2.2M
- Earning Date
- RVYL 11-13-2025
- SBFM 11-12-2025
- Dividend Yield
- RVYL N/A
- SBFM N/A
- EPS Growth
- RVYL N/A
- SBFM N/A
- EPS
- RVYL N/A
- SBFM N/A
- Revenue
- RVYL $48,904,000.00
- SBFM $36,341,741.00
- Revenue This Year
- RVYL N/A
- SBFM $21.12
- Revenue Next Year
- RVYL $297.49
- SBFM $44.89
- P/E Ratio
- RVYL N/A
- SBFM N/A
- Revenue Growth
- RVYL N/A
- SBFM 19.22
- 52 Week Low
- RVYL $0.25
- SBFM $1.17
- 52 Week High
- RVYL $2.33
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- RVYL 50.97
- SBFM 51.49
- Support Level
- RVYL $0.28
- SBFM $1.68
- Resistance Level
- RVYL $0.30
- SBFM $1.85
- Average True Range (ATR)
- RVYL 0.06
- SBFM 0.11
- MACD
- RVYL -0.00
- SBFM -0.02
- Stochastic Oscillator
- RVYL 21.29
- SBFM 30.77
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.